The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.077%)
Open: 33.00
High: 33.00
Low: 33.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

30 Jun 2014 07:00

RNS Number : 8277K
Praetorian Resources Limited
30 June 2014
 



30 June 2014

 

 

Praetorian Resources Limited ("Praetorian" or the "Company")

 

Issue of new shares

 

During July 2013 the Company announced that the majority of the Directors and advisors had agreed to accrue their contractual fees from 31 March 2013 as part of a cost saving and cash enhancement initiative. Those fees, in respect of services provided by two former directors, Mark Hohnen and Richard Lockwood and to two advisers, Malcolm Burne and Charles Cannon-Brookes have been accrued on the Company's balance sheet to date.

 

In line with this cash enhancement initiative, the Company has agreed with Messrs Hohnen, Lockwood, Burne and Cannon-Brookes to settle these accrued fees by the issue of 2,000,000 new Praetorian ordinary shares of no par value ("Ordinary Shares") representing a material discount to the combined total outstanding value of these contracts, which inclusive of notice periods equates to £297,500. Of these, 1,725,000 Ordinary Shares will be issued to Arlington Group Asset Management Limited (a company owned in equal share by Mr. Burne, Mr. Cannon-Brookes and Mr. Lockwood that contracts for their services) and 275,000 Ordinary Shares will be issued to Mark Hohnen. As a condition of this settlement, both Mr. Lockwood and Mr. Cannon-Brookes have agreed not to charge any further fees for the services they provide as part of the Advisory and Execution Team.

 

The placing of these Ordinary Shares constitutes a related party transaction under Rule 13 of the AIM Rules for Companies. The Director's, having consulted with the Company's nominated adviser, Grant Thornton UK LLP, consider that the terms of the transaction are fair and reasonable in so far as the Company's shareholders are concerned.

 

Application will be made for the admission to trading on AIM of the 2,000,000 new Ordinary Shares with admission expected to take place on or around 4 July 2014. Following admission, the Company's issued share capital will be 45,635,936 Ordinary Shares with each Ordinary Share carrying the right to one vote. The figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Disclosure and Transparency Rules.

 

The Company has in issue 23,205,443 subscription shares which carry voting rights only in limited circumstances. Subscription shareholders are not required to notify their interest in, or a change to their interest in, subscription shares under the Disclosure and Transparency Rules.

 

Robert King, Chairman stated:

"These most recent cash conservation initiatives will assist in retaining the Company's operating costs below GBP 250,000 per annum. I am pleased that Richard Lockwood and Charles Cannon-Brookes have agreed to continue to advise the Company without further charges, preferring to benefit from any uplift in the Company's share price.

 

The Board remain cognisant of the fact that the Company is undercapitalised and our focus remains on maximising the value from the existing portfolio while also actively searching for strategic opportunities to bring renewed positive momentum and scale to Praetorian."

 

 

 

 

Contacts:

For further information, please contact:

Praetorian Resources Limited

Robert King, Chairman

+44 (0) 1481 732 153

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson/David Hignell/Jamie Barklem

+44 (0)20 7383 5100

Pareto Securities Limited (Broker)

Guy Wilkes

+44 (0)20 7786 4370

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQDLFLZQFEBBF
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.